GMV
Click for more information
0.00% 3.9¢ g medical innovations holdings limited

Hydroxychloroquine study withdrawn - WHO restarts trials, page-2

  1. Poorrundownhill
    908 Posts.
    lightbulb Created with Sketch. 351
    clock Created with Sketch.
    05/06/20
    12:01
    Post #: 45057312
    Well good news for us. Interested to see how a certain somebody spins this in a negative light. The withdrawal was one of his supporting arguments for the "uselessness" of the VSMS patch approval due to its Hydrochloriquine ties.

    Anyways, comforting news.
    Last edited by Poorrundownhill: 05/06/20
    GMV Price at posting: 6.3¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MM1 Geochemical work at Newington picks up gold and copper anomalies for Midas
right-arrow Created with Sketch.
FHE Frontier Energy lines up $215 million debt financing from Mike Cannon-Brookes-backed Infradebt
right-arrow Created with Sketch.
PEC Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil
right-arrow Created with Sketch.
TRP Tissue Repairs soars nearly 32% on TGA approval for wound healing gel
right-arrow Created with Sketch.
MND Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?
right-arrow Created with Sketch.
NEWS Real estate dynamics & changes raise investor doubt
right-arrow Created with Sketch.
watchlist Created with Sketch. Add GMV (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.